171 related articles for article (PubMed ID: 33955863)
1. A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assay.
Raval JS; Montgomery ND; Rollins-Raval MA
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):302-303. PubMed ID: 33955863
[No Abstract] [Full Text] [Related]
2. Heparin-induced thrombocytopenia.
Greinacher A; Fürll B; Selleng S
Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
Kelton JG
Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
[No Abstract] [Full Text] [Related]
4. Immunobiology of heparin-induced thrombocytopenia.
Sandset PM
Curr Top Microbiol Immunol; 2010; 341():193-202. PubMed ID: 20369319
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.
Kannan M; Ahmad S; Ahmad F; Kale S; Hoppensteadt DA; Fareed J; Saxena R
Blood Coagul Fibrinolysis; 2005 Oct; 16(7):487-90. PubMed ID: 16175007
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
Warkentin TE; Davidson BL; Büller HR; Gallus A; Gent M; Lensing AWA; Piovella F; Prins MH; Segers AEM; Kelton JG
Chest; 2011 Aug; 140(2):366-373. PubMed ID: 21393394
[TBL] [Abstract][Full Text] [Related]
7. ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT?
Cuker A; Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():250-2. PubMed ID: 20008206
[TBL] [Abstract][Full Text] [Related]
8. New approaches to the diagnosis of heparin-induced thrombocytopenia.
Warkentin TE
Chest; 2005 Feb; 127(2 Suppl):35S-45S. PubMed ID: 15706029
[TBL] [Abstract][Full Text] [Related]
9. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
Whitlatch NL; Perry SL; Ortel TL
Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia and thrombosis.
Arepally G; Cines DB
Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
[No Abstract] [Full Text] [Related]
11. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
[TBL] [Abstract][Full Text] [Related]
12. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.
Alberio L; Kimmerle S; Baumann A; Taleghani BM; Biasiutti FD; Lämmle B
Am J Med; 2003 May; 114(7):528-36. PubMed ID: 12753876
[TBL] [Abstract][Full Text] [Related]
13. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
Dellaria SM; Greilich PE; Sarode R
Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011
[TBL] [Abstract][Full Text] [Related]
14. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
[No Abstract] [Full Text] [Related]
15. Measurement of heparin-dependent platelet antibodies in the diagnosis of heparin-induced thrombocytopenia: fact or fiction?
Parker RI
Crit Care Med; 2007 Jul; 35(7):1784-5. PubMed ID: 17581366
[No Abstract] [Full Text] [Related]
16. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
Davenport A
Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
[No Abstract] [Full Text] [Related]
17. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
Raschke RA; Curry SC; Warkentin TE; Gerkin RD
Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
[TBL] [Abstract][Full Text] [Related]
18. The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia.
Warkentin TE; Sheppard JI; Moore JC; Kelton JG
J Thromb Haemost; 2010 Jan; 8(1):216-8. PubMed ID: 19818000
[No Abstract] [Full Text] [Related]
19. The level of heparin-induced antibodies in correlation with the result of the flow cytometric functional assay in the patients with suspected HIT.
Maličev E; Maček Kvanka M; Klemenc P; Rožman P
J Clin Pathol; 2017 Dec; 70(12):1084-1087. PubMed ID: 28903994
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
Mattioli AV; Bonetti L; Sternieri S; Mattioli G
Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
